CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial. (2021)
Attributed to:
Large scale lentiviral vector production
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41591-021-01497-1
PubMed Identifier: 34642489
Publication URI: http://europepmc.org/abstract/MED/34642489
Type: Journal Article/Review
Volume: 27
Parent Publication: Nature medicine
Issue: 10
ISSN: 1078-8956